This inventor holds 3 USPTO granted patents and 3 published patent applications. Top assignees: Ajou University Industry-Academic Cooperation Foundation, Standigm Inc, Other. Active years: 2020-2026.
Company Filing History:
2 out of 380 
1 out of 3 
1 out of 834,350 Years Active: 2020-2026
Title: Jae Bong Kim: Innovator in Synucleinopathy Treatment
Introduction
Jae Bong Kim is a notable inventor based in Busan, South Korea. He has made significant contributions to the field of medical research, particularly in the treatment of synucleinopathies. With a total of 3 patents to his name, his work focuses on innovative pharmaceutical compositions aimed at addressing critical neurological conditions.
Latest Patents
One of Jae Bong Kim's latest patents is a composition for treating synucleinopathies. This composition includes efavirenz or a salt or solvate thereof, combined with a pharmaceutically acceptable carrier. It is designed to prevent or treat conditions such as Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. The composition works by hindering cell-to-cell transmission of alpha-synuclein, preventing intracellular aggregation of α-synuclein, and inhibiting the transmission of aggregated α-synuclein.
Another significant patent involves a pharmaceutical composition comprising an expression or activity inhibitor of c-src for preventing or treating synucleinopathy. This composition includes a substance that inhibits the expression or activity of c-src, which is crucial in inhibiting the aggregation and migration of α-synuclein. By mitigating the cytotoxic influence of α-synuclein on adjacent cells, this composition holds promise as a therapeutic agent for synucleinopathy.
Career Highlights
Throughout his career, Jae Bong Kim has been associated with the Ajou University Industry-Academic Cooperation Foundation. His work in this institution has allowed him to collaborate with other researchers and contribute to advancements in medical science.
Collaborations
Some of his notable coworkers include Sang Myun Park and Yu Ree Choi. Their collaborative efforts have furthered research in the field of synucleinopathies and have led to the development of innovative treatment options.
Conclusion
Jae Bong Kim's contributions to the field of synucleinopathy treatment through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical therapies aimed at improving the lives of those affected by neurological disorders.